These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22377693)

  • 1. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum α-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery.
    Beta J; Bredaki FE; Rodriguez Calvo J; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2011; 30(2):88-93. PubMed ID: 21411977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
    Schlosser H; Greiff R
    Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
    Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
    Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of an experiment in systematic prenatal screening for neural tube malformations by assay of alpha fetoproteins in dried blood samples (12,480 pregnancies)].
    Augier D; Sarramon MF; Rorive C; Dutau G; Sablayrolles B; Reme JM; Rochiccioli P
    J Genet Hum; 1985 Sep; 33(3-4):325-36. PubMed ID: 2414398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for trisomy 21 using alpha-fetoprotein.
    Bredaki FE; Wright D; Matos P; Syngelaki A; Nicolaides KH
    Fetal Diagn Ther; 2011; 30(3):215-8. PubMed ID: 21952001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chorionic villus sampling on serum alpha fetoprotein levels.
    Edersheim TG; Thornton YS; Alonso ML; Kazam E
    Am J Perinatol; 1985 Oct; 2(4):328-9. PubMed ID: 2413871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.